Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Research & Development: 2018-2023

Historic Research & Development for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to $101.0 million.

  • Therapeutics' Research & Development rose 37.58% to $26.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $101.0 million, marking a year-over-year increase of 50.56%. This contributed to the annual value of $101.0 million for FY2023, which is 50.56% up from last year.
  • According to the latest figures from FY2023, Therapeutics' Research & Development is $101.0 million, which was up 50.56% from $67.1 million recorded in FY2022.
  • Therapeutics' 5-year Research & Development high stood at $101.0 million for FY2023, and its period low was $34.9 million during FY2019.
  • Over the past 3 years, Therapeutics' median Research & Development value was $67.1 million (recorded in 2022), while the average stood at $75.0 million.
  • Data for Therapeutics' Research & Development shows a peak YoY skyrocketed of 50.56% (in 2023) over the last 5 years.
  • Over the past 5 years, Therapeutics' Research & Development (Yearly) stood at $34.9 million in 2019, then spiked by 30.29% to $45.5 million in 2020, then rose by 25.28% to $57.0 million in 2021, then increased by 17.72% to $67.1 million in 2022, then spiked by 50.56% to $101.0 million in 2023.